EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

SARM1 activation induces reversible mitochondrial dysfunction and can be prevented in human neurons by antisense oligonucleotides

Andrea Loreto, Kaitlyn M L Cramb, Lucy A McDermott, Christina Antoniou, Ilenia Cirilli, Maria Claudia Caiazza, Elisa Merlini, Peter Arthur-Farraj, W Daniel du Preez, Elliot D Mock, Hien T Zhao, David L Bennett und 3 weitere

Neurobiology of Disease · 2025-09 · 213 · 106986

DOI: 10.1016/j.nbd.2025.106986 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurobiology of Disease, 2025-09. Verfasst von Andrea Loreto und 14 weiteren Autor:innen. Beteiligte Einrichtung: Neuroscience, School of Medical Sciences, Faculty of Medicine and Health, University of Sydney, Sydney, Australia; Save Sight Institute, Faculty of M…. Hauptthemen laut MEDLINE: Armadillo Domain Proteins, Cytoskeletal Proteins, Mitochondria, Oligonucleotides, Antisense. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

SARM1 is a key regulator of a conserved program of axon degeneration increasingly linked to human neurodegenerative diseases. Pathological SARM1 activation causes rapid NAD consumption, disrupting cellular homeostasis and leading to axon degeneration. In this study, we develop antisense oligonucleotides (ASOs) targeting human SARM1, demonstrating robust neuroprotection against morphological, metabolic, and mitochondrial impairment in human iPSC-derived dopamine neurons induced by the lethal neurotoxin vacor, a potent SARM1 activator. Furthermore, our findings reveal that axon fragmentation can be prevented, and mitochondrial dysfunction reversed using the NAD precursor nicotinamide, a form of vitamin B3, even after SARM1 activation has occurred, when neurons are already unhealthy. This research identifies ASOs as a promising therapeutic strategy to block SARM1, and provides an extensive characterisation and further mechanistic insights that demonstrate the reversibility of SARM1 toxicity in human neurons. It also identifies the SARM1 activator vacor as a specific and reversible neuroablative agent in human neurons.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Armadillo Domain ProteinsCytoskeletal ProteinsMitochondriaOligonucleotides, AntisenseDopaminergic NeuronsMuscle ProteinsNeuronsHumansInduced Pluripotent Stem CellsAxonsCells, Cultured

Stichwörter der Autor:innen

ASOAxon degenerationMitochondrial dysfunctionNeuroablativeNicotinamideSARM1Vacor

Substanzen

Armadillo Domain ProteinsCytoskeletal ProteinsSARM1 protein, humanOligonucleotides, AntisenseMuscle Proteins

Autor:innen und Institutionen

  • Neuroscience, School of Medical Sciences, Faculty of Medicine and Health, University of Sydney, Sydney, Australia; Save Sight Institute, Faculty of Medicine and Health, University of Sydney, Sydney, Australia; Charles P…
  • Oxford Parkinson's Disease Centre and Department of Physiology, Anatomy & Genetics, Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, South Parks Road, Oxford OX1 3QU, U…
  • Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
  • John van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Forvie Site, Robinson Way, CB2 0PY Cambridge, UK.
  • Department of Clinical Sciences (DISCO), Section of Biochemistry, Polytechnic University of Marche, Via Ranieri 67, Ancona 60131, Italy.
  • Neuroscience, School of Medical Sciences, Faculty of Medicine and Health, University of Sydney, Sydney, Australia; Charles Perkins Centre, Faculty of Medicine and Health, University of Sydney, Sydney, Australia; John va…

Förderung

  • Wellcome Trust
  • Medical Research Council

Zitieren

APA

Loreto, A., Cramb, K. M. L., McDermott, L. A., Antoniou, C., Cirilli, I., Caiazza, M. C., Merlini, E., Arthur-Farraj, P., du Preez, W. D., Mock, E. D., Zhao, H. T., Bennett, D. L., Orsomando, G., Coleman, M. P., & Wade-Martins, R. (2025). SARM1 activation induces reversible mitochondrial dysfunction and can be prevented in human neurons by antisense oligonucleotides. Neurobiology of Disease, 213, 106986. https://doi.org/10.1016/j.nbd.2025.106986

Vancouver

Loreto A, Cramb KML, McDermott LA, Antoniou C, Cirilli I, Caiazza MC, et al. SARM1 activation induces reversible mitochondrial dysfunction and can be prevented in human neurons by antisense oligonucleotides. Neurobiology of Disease. 2025;213:106986. doi:10.1016/j.nbd.2025.106986

BibTeX
@article{Loreto2025,
  author = {Loreto, Andrea and Cramb, Kaitlyn M L and McDermott, Lucy A and Antoniou, Christina and Cirilli, Ilenia and Caiazza, Maria Claudia and Merlini, Elisa and Arthur-Farraj, Peter and du Preez, W Daniel and Mock, Elliot D and Zhao, Hien T and Bennett, David L and Orsomando, Giuseppe and Coleman, Michael P and Wade-Martins, Richard},
  title = {SARM1 activation induces reversible mitochondrial dysfunction and can be prevented in human neurons by antisense oligonucleotides},
  journal = {Neurobiology of Disease},
  year = {2025},
  volume = {213},
  pages = {106986},
  doi = {10.1016/j.nbd.2025.106986}
}
Kostenlos starten →